Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $101,552 - $110,959
-1,600 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $330,000 - $376,529
-5,500 Reduced 77.46%
1,600 $103,000
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $402,215 - $458,305
7,100 New
7,100 $414,000
Q1 2020

May 12, 2020

SELL
$62.63 - $80.22 $2.19 Million - $2.81 Million
-35,000 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$61.62 - $67.78 $2.16 Million - $2.37 Million
35,000 New
35,000 $2.27 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.